- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02324413
Pilot Study: Intraoperative Clonidine and Postoperative Behaviour
December 23, 2014 updated by: Richard Beringer
Randomised Controlled Pilot Study: Does Intraoperative Clonidine Reduce the Incidence of Post-hospitalisation Negative Behaviour Changes in Children Who Are Distressed During the Induction of General Anaesthesia?
Children who are upset during induction of general anaesthesia are frequently distressed postoperatively and are more likely to demonstrate negative behaviour changes.
This pilot study is a randomised controlled study of clonidine vs placebo during anaesthesia to identify whether postoperative behavioural disturbance may be minimised.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bristol, United Kingdom, BS2 8BJ
- Bristol Dental Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 10 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 2 to 10 years inclusive
- healthy (ASA 1 or 2)
Exclusion Criteria:
- inability of parents to understand english
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo
|
|
Active Comparator: clonidine
Clonidine intravenous 1 or 2 micrograms / kg
|
Comparison between placebo and 2 different concentrations of clonidine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of negative changes on the post-hospitalization behavior questionnaire
Time Frame: 24 hours and 7 days
|
24 hours and 7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2013
Primary Completion (Actual)
March 1, 2014
Study Completion (Actual)
March 1, 2014
Study Registration Dates
First Submitted
January 16, 2014
First Submitted That Met QC Criteria
December 23, 2014
First Posted (Estimate)
December 24, 2014
Study Record Updates
Last Update Posted (Estimate)
December 24, 2014
Last Update Submitted That Met QC Criteria
December 23, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Antihypertensive Agents
- Autonomic Agents
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Sympatholytics
- Clonidine
Other Study ID Numbers
- CH-2011-3668
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Negative Behaviour Change
-
Western University, CanadaNot yet recruitingSedentary Behaviour | Health Behaviour ChangeCanada
-
Western University, CanadaCompletedSedentary Lifestyle | Health Behaviour ChangeCanada
-
Western University, CanadaCompletedSedentary Lifestyle | Health Behaviour ChangeCanada
-
W.J. PasmanCompletedHealth Behaviour Change | Self-monitoring of HealthNetherlands
-
Western University, CanadaCompletedSedentary Behavior | Perceived Stress | Health Behaviour ChangeCanada
-
University of AlbertaCompleted
-
Western University, CanadaDuke UniversityCompletedHealth Behaviour ChangeCanada
-
University of OxfordClasado Biosciences LtdUnknown
-
Claude Bernard UniversityCompleted
-
University of NottinghamUnilever R&DCompletedBehaviourUnited Kingdom
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States